diZerega, Gere S.
Maulhardt, Holly A.
Verco, Shelagh J.
Marin, Alyson M.
Baltezor, Michael J.
Mauro, Samantha A.
Iacobucci, Marc A.
Funding for this research was provided by:
NanOlogy, LLC
Article History
Received: 3 November 2023
Accepted: 4 January 2024
First Online: 30 January 2024
Declarations
:
: Alyson M. Marin, Shelagh J. Verco, Samantha A. Mauro, and Holly A. Maulhardt report being full-time employees of US Biotest Inc; Gere S. diZerega and Marc A. Iacobucci report holding consultant/advisory roles, having stock ownership or receiving funding from NanOlogy, LLC.
: All institutional and national guidelines for the care and use of laboratory animals were followed. Investigational review boards for all participating clinical sites provided approval for protocol and informed consents for subjects in accordance with the Code of Federal Regulations and local requirements. All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2000 (5). Informed consent was obtained from all patients for being included in the study.